Genetics and new approaches to cancer therapy - Commentary

被引:26
作者
Cavenee, WK [1 ]
机构
[1] Univ Calif San Diego, Ctr Mol Genet, Dept Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA
关键词
D O I
10.1093/carcin/23.5.683
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:683 / 686
页数:4
相关论文
共 34 条
[1]  
BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251
[2]  
CADENA DL, 1994, J BIOL CHEM, V269, P260
[3]   Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII) [J].
Chu, CT ;
Everiss, KD ;
Wikstrand, CJ ;
Batra, SK ;
Kung, HJ ;
Bigner, DD .
BIOCHEMICAL JOURNAL, 1997, 324 :855-861
[4]  
DEPALAZZO IEG, 1993, CANCER RES, V53, P3217
[5]   Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens [J].
Feldkamp, MM ;
Lala, P ;
Lau, N ;
Roncari, L ;
Guha, A .
NEUROSURGERY, 1999, 45 (06) :1442-1453
[6]  
Han YC, 1996, CANCER RES, V56, P3859
[7]   SPECIFIC TARGETING OF A MUTANT, ACTIVATED EGF RECEPTOR FOUND IN GLIOBLASTOMA USING A MONOCLONAL-ANTIBODY [J].
HILLS, D ;
ROWLINSONBUSZA, G ;
GULLICK, WJ .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (04) :537-543
[8]   The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling [J].
Huang, HJS ;
Nagane, M ;
Klingbeil, CK ;
Lin, H ;
Nishikawa, R ;
Ji, XD ;
Huang, CM ;
Gill, GN ;
Wiley, HS ;
Cavenee, WK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (05) :2927-2935
[9]   PTB DOMAIN BINDING TO SIGNALING PROTEINS THROUGH A SEQUENCE MOTIF CONTAINING PHOSPHOTYROSINE [J].
KAVANAUGH, WM ;
TURCK, CW ;
WILLIAMS, LT .
SCIENCE, 1995, 268 (5214) :1177-1179
[10]  
Luwor RB, 2001, CANCER RES, V61, P5355